Piperidines
Aobchem Methanone (2 5-difluorophenyl)(2-methylphenyl)- | 95% | CAS 1094338-34-7 | C14H10F2O | 1g
Methanone (2 5-difluorophenyl)(2-methylphenyl)- | 95% | CAS 1094338-34-7 | C14H10F2O | 1g
Aobchem Methanone (2 5-difluorophenyl)(4-methoxyphenyl)- | 95% | CAS 1096971-14-0 | C14H10F2O2 | 250mg
Methanone (2 5-difluorophenyl)(4-methoxyphenyl)- | 95% | CAS 1096971-14-0 | C14H10F2O2 | 250mg
Aobchem Methanone (3-bromo-5-fluorophenyl)(3-fluorophenyl)- | 95% | CAS 1537494-14-6 | C13H7BrF2O | 250mg
Methanone (3-bromo-5-fluorophenyl)(3-fluorophenyl)- | 95% | CAS 1537494-14-6 | C13H7BrF2O | 250mg
Aobchem Methanone (2-fluoro-5-methylphenyl)(2-methylphenyl)- | 95% | CAS 1467385-31-4 | C15H13FO | 250mg
Methanone (2-fluoro-5-methylphenyl)(2-methylphenyl)- | 95% | CAS 1467385-31-4 | C15H13FO | 250mg
Aobchem Methanone (2 5-difluorophenyl)(2-methylphenyl)- | 95% | CAS 1094338-34-7 | C14H10F2O | 250mg
Methanone (2 5-difluorophenyl)(2-methylphenyl)- | 95% | CAS 1094338-34-7 | C14H10F2O | 250mg
Aobchem Methanone (2-fluoro-5-methylphenyl)(2-methylphenyl)- | 95% | CAS 1467385-31-4 | C15H13FO | 1g
Methanone (2-fluoro-5-methylphenyl)(2-methylphenyl)- | 95% | CAS 1467385-31-4 | C15H13FO | 1g
Aobchem Methanone (3-bromo-5-fluorophenyl)(3-fluorophenyl)- | 95% | CAS 1537494-14-6 | C13H7BrF2O | 1g
Methanone (3-bromo-5-fluorophenyl)(3-fluorophenyl)- | 95% | CAS 1537494-14-6 | C13H7BrF2O | 1g
Aobchem Methanone (3-chloro-4-methylphenyl)(3-methylphenyl)- | 95% | CAS 1332348-85-2 | C15H13ClO | 500mg
Methanone (3-chloro-4-methylphenyl)(3-methylphenyl)- | 95% | CAS 1332348-85-2 | C15H13ClO | 500mg
Aobchem Methanone (4-benzoylphenyl)cyclohexyl- | 95% | CAS 917567-34-1 | C20H20O2 | 1g
Methanone (4-benzoylphenyl)cyclohexyl- | 95% | CAS 917567-34-1 | C20H20O2 | 1g
Aobchem Methanone 2-dibenzothienylphenyl- | 95% | CAS 6407-30-3 | C19H12OS | 500mg
Methanone 2-dibenzothienylphenyl- | 95% | CAS 6407-30-3 | C19H12OS | 500mg
Medchemexpress LLC Nelfinavir Mesylate (AG 1343 Mesylate) | 159989-65-8 | C33H49N3O7S2 | 50 MG
Nelfinavir Mesylate is a potent, orally bioavailable inhibitor of HIV-1 protease (Ki=2 nM) used in the treatment of HIV infection. It also acts as a broad-spectrum anticancer agent.
- Potent and orally bioavailable HIV-1 protease inhibitor (Ki=2 nM) for HIV infection.
- Functions as a broad-spectrum anticancer agent.
- Inhibits the proliferation of multiple myeloma cells in a dose-dependent manner (IC50 of 1-5 μM).
- Impairs 26S chymotrypsin-like proteasome activity.
- Triggers apoptosis in myeloma cell lines and fresh plasma cells.
- Decreases the phosphorylation of AKT, STAT-3, and ERK1/2, and activates the pro-apoptotic pathway of the unfolded protein response system.
- Also identified as a SARS-CoV 3CLpro inhibitor with an IC50 of 35.93 μM.
Medchemexpress LLC IOWH-032 | 1191252-49-9 | 99.6% | 545.18 | 50 MG
IOWH-032 is a synthetic anti-secretory molecule and a potent CFTR inhibitor with an IC50 value of 8 μM. It also functions as an anti-diarrheal agent.
- Potent CFTR inhibitor with an IC50 value of 8 μM.
- Functions as an anti-diarrheal agent.
- Increases ACE-2 expression in SARS-CoV-2 infected CFBE41o- WT cells (10 μM; 0-72 h).
AdipoGen Ropivacaine HCl H2O
Chemical. CAS 132112-35-7. Formula C17H26N2O . HCl . H2O. MW 274.4 . 36.5 . 18.0. Synthetic. Ropivacaine is a long-acting amide local anaesthetic agent. Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. It is a pure S-enantiomer and less lipophilic than racemic sodium channel blockers, such as bupivacaine and is less likely to penetrate large myelinated motor fibres, resulting in a relatively reduced motor blockade. Thus, ropivacaine has a greater degree of motor sensory differentiation, which could be useful when motor blockade is undesirable. The reduced lipophilicity is also associated with decreased potential for central nervous system toxicity and cardiotoxicity.
Medchemexpress LLC Ropivacaine | 84057-95-4 | 100.0% | 5 MG
Ropivacaine is a potent sodium channel blocker that blocks impulse conduction by reversibly inhibiting sodium ion influx in nerve fibers. It also acts as an inhibitor of K2P (two-pore domain potassium channel) TREK-1. It is utilized in the research of neuropathic pain management.
- Blocks impulse conduction by reversibly inhibiting sodium ion influx in nerve fibers.
- Acts as an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane.
- Utilized in the research of neuropathic pain management.
Medchemexpress LLC HY-108361 10mg Medchemexpress, CCG-203971 CAS:1443437-74-8 Purity:>98%
Medchemexpress, HY-108361 10mg CCG-203971 CAS:1443437-74-8 CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC50 =6.4 μM). CCG-203971 inhibits PC-3 cell migration with an IC50 of 4.2 μM. Potential anti-metastasis Agent. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.